Kyowa Hakko Kirin Starts Phase II For Adult T-cell Lymphoma Antibody Drug
This article was originally published in PharmAsia News
Kyowa Hakko Kirin commenced a Japanese domestic Phase II trial to confirm safety and efficacy for KW-0761 to treat adult patients with CCR4-positive T-cell lymphoma
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.